Delivery Order SPE2DE21D7020-SPE2D626F38D7

Boston Scientific Corp has been awarded a fixed-price delivery order with economic price adjustment by the Defense Health Agency's Medical Supply Chain division, valued at $16,009.60, with an award date of December 18, 2025, and an ultimate completion date of December 26, 2025. The contract, designated as a delivery order against an existing blanket purchase agreement, will be performed in Marlborough, Massachusetts, where Boston Scientific maintains its corporate headquarters. No small business set-aside was utilized for this procurement, allowing Boston Scientific to compete on an unrestricted basis. This award is consistent with Boston Scientific's established role as a critical supplier of specialized medical devices to federal healthcare agencies, including the Defense Health Agency and Veterans Affairs medical centers.

This delivery order represents a continuation of Boston Scientific's ongoing support to the Defense Health Agency's Medical Supply Chain through the company's single-award blanket purchase agreement valued at $750,000, which was established on March 31, 2025, with a completion date of March 30, 2030. Under this indefinite delivery vehicle, Boston Scientific serves as the sole supplier of radiation treatment devices, including yttrium-90 glass microspheres and related radiopharmaceuticals used in cancer treatment across military healthcare facilities and VA medical centers. The award demonstrates the federal government's reliance on Boston Scientific's capability to maintain supply chain continuity for complex, specialized oncology equipment while meeting rapid resupply requirements for defense and veterans healthcare enterprises.